Abstract Topical minoxidil (5% foam, 5% solution, and 2% solution) is FDA-approved for
androgenetic alopecia (AGA) in men and women. Mechanism of action: Minoxidil acts …

Background Androgenetic alopecia (AGA) is the most common cause of hair loss, often
challenging to treat. While oral finasteride (1 mg/d) is an FDA-approved treatment for male …

Platelet-rich plasma (PRP) has emerged as a new treatment modality in regenerative plastic
surgery, and preliminary evidence suggests that it might have a beneficial role in hair …

Background: Platelet-rich plasma (PRP) is defined as an autologous concentration of
plasma with a greater count of platelets than that of whole blood. Its action depends on the …

The number of articles evaluating platelet-rich plasma (PRP) efficacy in androgenic alopecia
(AGA) have exponentially increased during the last decade. A systematic review on this field …

Background Androgenetic alopecia (AGA) is one of the most common chronic problems
seen by dermatologists worldwide. It is characterized by progressive hair loss, especially of …

To investigate the safety and clinical efficacy of AA‐PRP injections for pattern hair loss. AA‐
PRP, prepared from a small volume of blood, was injected on half of the selected patients' …

Hair is a deeply rooted component of identity and culture. Recent articles in this series have
focused on scientific evidence relating to hair growth and new insights into the pathogenesis …

Tissue engineering in hair regrowth aims to develop innovative and not‐invasive
procedures to advance the hair regrowth. A placebo‐controlled, randomized, evaluator …

Objectives: A retrospective case-series study comparing autologous activated platelet-rich
plasma (AA-PRP) versus autologous non-activated platelet-rich plasma (A-PRP) in hair re …